General Information of the Compound
Compound ID
CP0037570
Compound Name
BEVYXXA
    Show/Hide
Synonyms
330942-05-7
74RWP7W0J9
BETRIXABAN
Betrixaban
Betrixaban (USAN)
Betrixaban [USAN:INN]
Bevyxxa
D0J0BU
EX-A358
GTPL9602
MolPort-009-682-948
PRT 054021
PRT054021
QCR-99
SCHEMBL158591
UNII-74RWP7W0J9
ZINC3
betrixaban maleate
betrixaban/
    Show/Hide
Structure
Formula
C23H22ClN5O3
Molecular Weight
451.914
Canonical SMILES
COc1ccc(NC(=O)c2ccc(cc2)C(=N)N(C)C)c(c1)C(=O)Nc1ccc(Cl)cn1
    Show/Hide
InChI
InChI=1S/C23H22ClN5O3/c1-29(2)21(25)14-4-6-15(7-5-14)22(30)27-19-10-9-17(32-3)12-18(19)23(31)28-20-11-8-16(24)13-26-20/h4-13,25H,1-3H3,(H,27,30)(H,26,28,31)
    Show/Hide
InChIKey
XHOLNRLADUSQLD-UHFFFAOYSA-N
CAS
330942-05-7
Physicochemical Property
logP
4.13517
Rotatable Bonds
6
Heavy Atom Count
32
Polar Areas
107.41
Hydrogen Bond Donor Count
3
Hydrogen Bond Acceptor Count
5
Complexity
32

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 10275777
SID: 15280787
ChEMBL ID
CHEMBL512351
DrugBank ID
DB12364
Clinical Information about the Compound
Drug 1 ( BETRIXABAN )
Drug Name BETRIXABAN
Company Portola Pharmaceuticals
Indication
Venous thromboembolism
Approved
Cerebrovascular ischaemia
Phase 3
Target(s)
Coagulation factor Xa (F10)
Modulator